USA - NASDAQ:CRON - CA22717L1013 - Common Stock
Overall CRON gets a fundamental rating of 5 out of 10. We evaluated CRON against 192 industry peers in the Pharmaceuticals industry. No worries on liquidiy or solvency for CRON as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, CRON is valued expensive at the moment.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.57% | ||
| ROE | 1.71% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 14.19% | ||
| GM | 32.74% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 7.55 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 24.65 | ||
| Quick Ratio | 23.53 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.4 | ||
| Fwd PE | 35.29 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.52
+0.04 (+1.61%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.4 | ||
| Fwd PE | 35.29 | ||
| P/S | 7.41 | ||
| P/FCF | N/A | ||
| P/OCF | 48.18 | ||
| P/B | 0.89 | ||
| P/tB | 0.96 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.57% | ||
| ROE | 1.71% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 14.19% | ||
| GM | 32.74% | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 224.14% | ||
| Cap/Sales | 22.6% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 24.65 | ||
| Quick Ratio | 23.53 | ||
| Altman-Z | 7.55 |
ChartMill assigns a fundamental rating of 5 / 10 to CRON.
ChartMill assigns a valuation rating of 1 / 10 to CRONOS GROUP INC (CRON). This can be considered as Overvalued.
CRONOS GROUP INC (CRON) has a profitability rating of 3 / 10.
The Earnings per Share (EPS) of CRONOS GROUP INC (CRON) is expected to decline by -115.3% in the next year.